New Key Statistics Module, Z-Score and F-Score
SHSE:603739 Key Ratios
Market Cap ¥ M | 2,917.76 |
Enterprise Value ¥ M | 3,329.89 |
P/E(ttm) | 44.81 |
PE Ratio without NRI | 38.58 |
Forward PE Ratio | 27.88 |
Price/Book | 1.71 |
Price/Sales | 2.38 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.33 |
Revenue (TTM) ¥ M | 1,264.00 |
EPS (TTM) ¥ | 0.26 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -0.80 |
y-y EBITDA Growth Rate % | 26.00 |
EV-to-EBIT | 22.75 |
EV-to-EBITDA | 22.75 |
PEG | -- |
Shares Outstanding M | 253.03 |
Net Margin (%) | 5.24 |
Operating Margin % | 12.34 |
Pre-tax Margin (%) | 9.81 |
Quick Ratio | 0.92 |
Current Ratio | 1.10 |
ROA % (ttm) | 2.20 |
ROE % (ttm) | 3.87 |
ROIC % (ttm) | 4.76 |
Dividend Yield % | 0.85 |
Altman Z-Score | 2.41 |
SHSE:603739 Number of Guru Trades
SHSE:603739 Volume of Guru Trades
Gurus Latest Trades with SHSE:603739
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603739 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Qingdao Vland Biotech Co Ltd Insider Transactions
No Available Data